search
Back to results

Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

Primary Purpose

Spinal Cord Injuries

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Bladder and Pelvic Floor Muscle Training
Sponsored by
Iva Hauptmannova
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injuries focused on measuring Spinal cord stimulation, Pelvic floor physiotherapy, Incontinence, Bladder overactivity, Neurogenic detrusor overactivity

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Supra-sacral spinal cord injury over 6 months ago
  • Previous urodynamics and management by the Neuro-urology Consultants
  • Proven NDO from latest urodynamics

Exclusion Criteria:

  • Participants under 16 years of age
  • Non-stable SCI or metastatic cord disease
  • Intra-detrusor botulinum toxin injections in previous 6 months
  • Bladder infection on day of investigation
  • Pregnant or trying for a baby (females)
  • Cardiac pacemaker, bladder stimulator or baclofen pump in situ
  • Metal work at thoraco-lumbar level of stimulation
  • Poorly controlled Autonomic Dysreflexia
  • Currently involved in a clinical trial
  • Previous surgical intervention on bladder/sphincters
  • Active sepsis
  • Poorly controlled epilepsy. Acceptable where epilepsy is controlled by drugs or there have been no fits experienced for a reasonable period
  • Patients with a cancerous tumour in the area of the electrical stimulation
  • Patients without the capacity to consent

Sites / Locations

  • Royal National Orthopaedic HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Bladder and Pelvic Floor Muscle Training

Control

Arm Description

Participants randomised to the intervention group will complete an 8-week bladder and PFMT programme, both at the LSCIC and at home. They will be invited to 3 face-to-face follow up appointments over the 8-weeks, where they will meet with a physiotherapist to check their technique and monitor their progress. At home participants will receive a daily text reminder to complete their PFM training, they will also receive a weekly phone call from a member of the research team who will check how they are managing and whether they have any questions. At the end of the programme, participants will be asked to repeat the questionnaires and have their pelvic floor re-assessed. Following this, they will complete the urodynamic investigation with tSCS.

Participants randomised to the control group will continue with their usual care for 8-weeks. They will return to repeat their baseline questionnaires and have their pelvic floor re-assessed. Finally, they will complete tSCS bladder filling and emptying cycles with urodynamics.

Outcomes

Primary Outcome Measures

Change in maximum cystometric capacity (MCC) from baseline to follow up
Bladder capacity from Cystometrogram/Urodynamic procedures (ml)
Change in maximum detrusor pressure during voiding (MDPvoid) from baseline to follow up
Voiding detrusor pressure measured from Cystometrogram/Urodynamic procedures (cmH20)
Change in bladder voiding efficiency from baseline to follow up
Bladder voiding efficiency measured from Cystometrogram/Urodynamic procedures, [[volume voided/volume voided+post void residual)*100] (%)

Secondary Outcome Measures

Pelvic Floor Oxford Grading Score
Measure of pelvic floor muscle strength, graded 0-5
The Neurogenic Bladder Symptom Score (NBSS)
Validated 24-item questionnaire, three domains: incontinence, storage and voiding, consequences (score 0-28)
Neurogenic Bowel Dysfunction Score (NBDS)
Bowel dysfunction questionnaire, includes questions on bowel symptoms, medication, and incontinence (score 0-47)
Arizona Sexual Experiences Scale (ASEX)
Five-item rating scale measuring sex drive, arousal, vaginal lubrication/penile erection, ability to reach orgasm, and satisfaction from orgasm (Score 3-30)
Quality of Life Questionnaire EQ-5D-5L
Five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scoring 1-5 on each dimension, and a VAS scale of overall health 0-100.
The Qualiveen Questionnaire
30-item questionnaire, with health-related quality of life questions specific to individuals with neurogenic urinary dysfunction. Total score is mean of eight scores: bother with limitations, fears, feelings, and frequency of limitations.
Electromyography (EMG) of resting tone and maximum voluntary pelvic floor contraction
Use of vaginal/anal probe to capture resting tone and maximum voluntary pelvic floor contraction (mV)

Full Information

First Posted
August 15, 2022
Last Updated
August 15, 2022
Sponsor
Iva Hauptmannova
Collaborators
International Spinal Research Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT05504200
Brief Title
Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training
Official Title
Promoting Restoration of Function of Co-ordinated Bladder Storage and Voiding Following Spinal Cord Injury by Combination of Transcutaneous Spinal Cord Stimulation and Bladder & Pelvic Floor Muscle Training Training
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 16, 2022 (Actual)
Primary Completion Date
August 1, 2023 (Anticipated)
Study Completion Date
September 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Iva Hauptmannova
Collaborators
International Spinal Research Trust

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Spinal Cord Injury (SCI) disrupts signals between the brain and the rest of the body, this includes signals needed to control the bladder and bowels. Spinal cord stimulation (SCS) (electrical stimulation through electrodes placed on the skin over the spine) has shown potential to improve bladder function. Additionally pelvic floor muscle training (PFMT), has been shown to help control bladder overactivity and reduce incontinence in people with a SCI. This study will investigate PFMT with SCS, and its effects on restoring bladder function, and continence. We aim to recruit 25 participants. Those eligible will be patients from the London Spinal Cord Injury Centre with a supra-sacral SCI (>6 months post-injury), aged 16 years old and above.
Detailed Description
The first five participants who volunteer will be invited to complete 'SCS optimisation'. Testing different SCS electrode positions and stimulation parameters with pelvic floor exercises and during urodynamics (measurement of pressure changes during filling and emptying of the bladder). For the main study, all participants will complete baseline assessments (week 1) which include: bladder, bowel, sexual function, and quality of life questionnaires, a pelvic floor assessment, and urodynamics. Assessments will be repeated at week 8, and week 14. After baseline assessments, participants will be randomly allocated to one of two groups. The intervention group will receive 8-weeks of at home PFMT, this will include 3 face-to-face visits, daily text reminders, and a weekly phone call. The control group will continue with usual care for 8-weeks. At the end of the 8-weeks, all participants will be re-assessed, and will then complete a single session of SCS with urodynamics. Participants will return for their final assessment 6-weeks later (week 14). Participants allocated to the control group will be offered PFMT at the end of the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries
Keywords
Spinal cord stimulation, Pelvic floor physiotherapy, Incontinence, Bladder overactivity, Neurogenic detrusor overactivity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
25 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Bladder and Pelvic Floor Muscle Training
Arm Type
Experimental
Arm Description
Participants randomised to the intervention group will complete an 8-week bladder and PFMT programme, both at the LSCIC and at home. They will be invited to 3 face-to-face follow up appointments over the 8-weeks, where they will meet with a physiotherapist to check their technique and monitor their progress. At home participants will receive a daily text reminder to complete their PFM training, they will also receive a weekly phone call from a member of the research team who will check how they are managing and whether they have any questions. At the end of the programme, participants will be asked to repeat the questionnaires and have their pelvic floor re-assessed. Following this, they will complete the urodynamic investigation with tSCS.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Participants randomised to the control group will continue with their usual care for 8-weeks. They will return to repeat their baseline questionnaires and have their pelvic floor re-assessed. Finally, they will complete tSCS bladder filling and emptying cycles with urodynamics.
Intervention Type
Other
Intervention Name(s)
Bladder and Pelvic Floor Muscle Training
Intervention Description
The intervention group will receive 8-weeks of at home PFMT, this will include 3 face-to-face visits, daily text reminders, and a weekly phone call.
Primary Outcome Measure Information:
Title
Change in maximum cystometric capacity (MCC) from baseline to follow up
Description
Bladder capacity from Cystometrogram/Urodynamic procedures (ml)
Time Frame
Week 1, 8 and 14
Title
Change in maximum detrusor pressure during voiding (MDPvoid) from baseline to follow up
Description
Voiding detrusor pressure measured from Cystometrogram/Urodynamic procedures (cmH20)
Time Frame
Week 1, 8 and 14
Title
Change in bladder voiding efficiency from baseline to follow up
Description
Bladder voiding efficiency measured from Cystometrogram/Urodynamic procedures, [[volume voided/volume voided+post void residual)*100] (%)
Time Frame
Week 1, 8 and 14
Secondary Outcome Measure Information:
Title
Pelvic Floor Oxford Grading Score
Description
Measure of pelvic floor muscle strength, graded 0-5
Time Frame
Week 1, 8 and 14
Title
The Neurogenic Bladder Symptom Score (NBSS)
Description
Validated 24-item questionnaire, three domains: incontinence, storage and voiding, consequences (score 0-28)
Time Frame
Week 1, 8 and 14
Title
Neurogenic Bowel Dysfunction Score (NBDS)
Description
Bowel dysfunction questionnaire, includes questions on bowel symptoms, medication, and incontinence (score 0-47)
Time Frame
Week 1, 8 and 14
Title
Arizona Sexual Experiences Scale (ASEX)
Description
Five-item rating scale measuring sex drive, arousal, vaginal lubrication/penile erection, ability to reach orgasm, and satisfaction from orgasm (Score 3-30)
Time Frame
Week 1, 8 and 14
Title
Quality of Life Questionnaire EQ-5D-5L
Description
Five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scoring 1-5 on each dimension, and a VAS scale of overall health 0-100.
Time Frame
Week 1, 8 and 14
Title
The Qualiveen Questionnaire
Description
30-item questionnaire, with health-related quality of life questions specific to individuals with neurogenic urinary dysfunction. Total score is mean of eight scores: bother with limitations, fears, feelings, and frequency of limitations.
Time Frame
Week 1, 8 and 14
Title
Electromyography (EMG) of resting tone and maximum voluntary pelvic floor contraction
Description
Use of vaginal/anal probe to capture resting tone and maximum voluntary pelvic floor contraction (mV)
Time Frame
Week 1, 8 and 14

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Supra-sacral spinal cord injury over 6 months ago Previous urodynamics and management by the Neuro-urology Consultants Proven NDO from latest urodynamics Exclusion Criteria: Participants under 16 years of age Non-stable SCI or metastatic cord disease Intra-detrusor botulinum toxin injections in previous 6 months Bladder infection on day of investigation Pregnant or trying for a baby (females) Cardiac pacemaker, bladder stimulator or baclofen pump in situ Metal work at thoraco-lumbar level of stimulation Poorly controlled Autonomic Dysreflexia Currently involved in a clinical trial Previous surgical intervention on bladder/sphincters Active sepsis Poorly controlled epilepsy. Acceptable where epilepsy is controlled by drugs or there have been no fits experienced for a reasonable period Patients with a cancerous tumour in the area of the electrical stimulation Patients without the capacity to consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hannah Houliston
Phone
02039470606
Email
hannah.houliston@nhs.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frank Lee
Organizational Affiliation
Royal National Orthopaedic Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Royal National Orthopaedic Hospital
City
Stanmore
ZIP/Postal Code
HA7 4LP
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hannah Houliston
Phone
02039470606
Email
hannah.houliston@nhs.net

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35778466
Citation
Herrity AN, Aslan SC, Mesbah S, Siu R, Kalvakuri K, Ugiliweneza B, Mohamed A, Hubscher CH, Harkema SJ. Targeting bladder function with network-specific epidural stimulation after chronic spinal cord injury. Sci Rep. 2022 Jul 1;12(1):11179. doi: 10.1038/s41598-022-15315-2.
Results Reference
background
PubMed Identifier
30008661
Citation
Gad PN, Kreydin E, Zhong H, Latack K, Edgerton VR. Non-invasive Neuromodulation of Spinal Cord Restores Lower Urinary Tract Function After Paralysis. Front Neurosci. 2018 Jun 29;12:432. doi: 10.3389/fnins.2018.00432. eCollection 2018.
Results Reference
background
PubMed Identifier
31956301
Citation
Doherty S, Vanhoestenberghe A, Duffell L, Hamid R, Knight S. A Urodynamic Comparison of Neural Targets for Transcutaneous Electrical Stimulation to Acutely Suppress Detrusor Contractions Following Spinal Cord Injury. Front Neurosci. 2019 Dec 17;13:1360. doi: 10.3389/fnins.2019.01360. eCollection 2019.
Results Reference
background
PubMed Identifier
32355163
Citation
Doherty SP, Vanhoestenberghe A, Duffell LD, Hamid R, Knight SL. Ambulatory urodynamic monitoring assessment of dorsal genital nerve stimulation for suppression of involuntary detrusor contractions following spinal cord injury: a pilot study. Spinal Cord Ser Cases. 2020 Apr 30;6(1):30. doi: 10.1038/s41394-020-0279-4.
Results Reference
background
PubMed Identifier
32759239
Citation
Xu L, Fu C, Zhang Q, Xiong F, Peng L, Liang Z, Chen L, He C, Wei Q. Efficacy of biofeedback, repetitive transcranial magnetic stimulation and pelvic floor muscle training for female neurogenic bladder dysfunction after spinal cord injury: a study protocol for a randomised controlled trial. BMJ Open. 2020 Aug 5;10(8):e034582. doi: 10.1136/bmjopen-2019-034582.
Results Reference
background
PubMed Identifier
29574482
Citation
Elmelund M, Biering-Sorensen F, Due U, Klarskov N. The effect of pelvic floor muscle training and intravaginal electrical stimulation on urinary incontinence in women with incomplete spinal cord injury: an investigator-blinded parallel randomized clinical trial. Int Urogynecol J. 2018 Nov;29(11):1597-1606. doi: 10.1007/s00192-018-3630-6. Epub 2018 Mar 24.
Results Reference
background
PubMed Identifier
26238317
Citation
Vasquez N, Knight SL, Susser J, Gall A, Ellaway PH, Craggs MD. Pelvic floor muscle training in spinal cord injury and its impact on neurogenic detrusor over-activity and incontinence. Spinal Cord. 2015 Dec;53(12):887-9. doi: 10.1038/sc.2015.121. Epub 2015 Aug 4.
Results Reference
background

Learn more about this trial

Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

We'll reach out to this number within 24 hrs